Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-25 @ 2:44 AM
NCT ID:
NCT03480633
Eligibility Criteria:
Inclusion criteria for patients with HF:
* 18 years and older
* History of clinical symptoms consistent with HF and at least one of the following supporting evidence of HF:
* NT-proBNP \> 125 pg/mL
* BNP \> 35 pg/mL
* Capillary wedge pressure ≥ 15 mmHg on right heart catheterization or CI \<2.8 L/min/m2
* LVEDP ≥ 15 mmHg
* Radiographic evidence of pulmonary edema
* Improvement in symptoms with diuretic initiation of increase
* CPET evidence of cardiac etiology of symptoms
HFpEF: LVEF ≥ 50% HFrEF: LVEF \<50%
Exclusion criteria (for all patients, including both those with HFpEF and HFrEF):
\- End stage renal disease on dialysis
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03480633
Study Brief:
Protocol Section:
NCT03480633